Glycogen accumulations in the cerebral cortex in Alzheimer's disease
- PMID: 3037842
- DOI: 10.1007/BF00693786
Glycogen accumulations in the cerebral cortex in Alzheimer's disease
Abstract
The fine structure of granular glycogen bodies (GGB) within the grey matter of the temporal cortex of 11 patients with Alzheimer's disease is described. GGB measure up to 50 microns in diameter and consist of densely packed alpha or beta glycogen granules (never both), neither of which are membrane bound. They were noted in axons, both myelinated and unmyelinated (sometimes close to the dystrophic neurites of senile plaques), and also in other processes of indeterminate origin. Their appearance may relate to disturbances of axonal transport resulting from damage to terminals within evolving senile plaques.
Similar articles
-
Glycogen accumulation of the aging human brain.Mech Ageing Dev. 1985 Jun;31(1):25-35. doi: 10.1016/0047-6374(85)90024-7. Mech Ageing Dev. 1985. PMID: 2993763
-
Senile plaque-like structures: observation of a probably unknown type of senile plaque by periodic-acid methenamine silver (PAM) electron microscopy.Acta Neuropathol. 1989;78(2):137-42. doi: 10.1007/BF00688201. Acta Neuropathol. 1989. PMID: 2473593
-
Immunogold electron microscopic study of cerebrovascular and senile plaque amyloid using anti-beta protein antibody.Prog Clin Biol Res. 1989;317:953-63. Prog Clin Biol Res. 1989. PMID: 2690130 Review.
-
Diffuse Lewy body disease: an autopsy case.Acta Med Okayama. 1987 Jun;41(3):133-9. doi: 10.18926/AMO/31770. Acta Med Okayama. 1987. PMID: 2820201
-
Mechanisms of amyloid plaque pathogenesis.Acta Neuropathol. 2007 Dec;114(6):551-71. doi: 10.1007/s00401-007-0284-8. Epub 2007 Sep 6. Acta Neuropathol. 2007. PMID: 17805553 Review.
Cited by
-
From axonal transport to mitochondrial trafficking: What can we learn from Manganese-Enhanced MRI studies in mouse models of Alzheimers disease?Curr Med Imaging Rev. 2011;7(1):16-27. doi: 10.2174/157340511794653478. Curr Med Imaging Rev. 2011. PMID: 40099016 Free PMC article.
-
Neuronal glycogen breakdown mitigates tauopathy via pentose-phosphate-pathway-mediated oxidative stress reduction.Nat Metab. 2025 Jul;7(7):1375-1391. doi: 10.1038/s42255-025-01314-w. Epub 2025 Jun 30. Nat Metab. 2025. PMID: 40588539
-
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.Neurotherapeutics. 2023 Oct;20(6):1808-1819. doi: 10.1007/s13311-023-01434-9. Epub 2023 Sep 12. Neurotherapeutics. 2023. PMID: 37700152 Free PMC article.
-
Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.Adv Neurobiol. 2019;23:17-81. doi: 10.1007/978-3-030-27480-1_2. Adv Neurobiol. 2019. PMID: 31667805 Free PMC article. Review.
-
Neuronal Glycogen Breakdown Mitigates Tauopathy via Pentose Phosphate Pathway-Mediated Oxidative Stress Reduction.Res Sq [Preprint]. 2023 Nov 8:rs.3.rs-3526342. doi: 10.21203/rs.3.rs-3526342/v1. Res Sq. 2023. Update in: Nat Metab. 2025 Jul;7(7):1375-1391. doi: 10.1038/s42255-025-01314-w. PMID: 37986935 Free PMC article. Updated. Preprint.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical